Page 2 - Atreca Company Profile News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Atreca company profile. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Atreca Company Profile Today - Breaking & Trending Today

Atreca (NASDAQ:BCEL) Trading 3.2% Higher

Atreca, Inc. (NASDAQ:BCEL – Get Rating) shot up 3.2% during mid-day trading on Monday . The company traded as high as $1.05 and last traded at $1.03. 71,794 shares traded hands during trading, a decline of 51% from the average session volume of 146,446 shares. The stock had previously closed at $1.00. Analyst Upgrades and […] ....

Stifel Nicolaus , Wealth Management , Renaissance Technologies , Blackrock Inc , Ef Hutton Acquisition Co , Advisor Group Holdings Inc , Dynamic Technology Lab Private Ltd , Atreca Inc , Get Rating , Group Holdings , Technology Lab Private Ltd , Atreca Daily , Nasdaq Bcel ,

Atreca, Inc. (NASDAQ:BCEL) Expected to Earn Q2 2023 Earnings of ($0.59) Per Share

Atreca, Inc. (NASDAQ:BCEL – Get Rating) – Equities research analysts at Wedbush raised their Q2 2023 earnings per share estimates for shares of Atreca in a research note issued to investors on Thursday, May 11th. Wedbush analyst R. Driscoll now expects that the company will post earnings per share of ($0.59) for the quarter, up […] ....

Stifel Nicolaus , Ef Hutton Acquisition Co , Renaissance Technologies , Atreca Inc , Millennium Management , Ensign Peak Advisors Inc , Get Rating , Capital Management , Point Capital Management , Peak Advisors Inc , State Street Corp , Street Corp , Atreca Daily , Nasdaq Bcel , Earnings Estimates ,

Reviewing Atreca (NASDAQ:BCEL) & Mustang Bio (NASDAQ:MBIO)

Atreca (NASDAQ:BCEL – Get Rating) and Mustang Bio (NASDAQ:MBIO – Get Rating) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their risk, earnings, profitability, dividends, analyst recommendations, valuation and institutional ownership. Institutional & Insider Ownership 40.2% of Atreca shares are owned […] ....

Robert Axtell , Daniel Emerling , Williamh Robinson , Wayne Volkmuth , Titoa Serafini , Jeremy Sokolove , Paulettea Dillon , Lawrencej Steinman , Atreca Inc , Mustang Bio Inc , Get Rating , Mustang Bio , Given Mustang Bio , Guy Cavet , Jonathan Woo , Yann Chong Tan , San Carlos , Atreca Daily , Nasdaq Bcel , Stock Comparison , Stock Analysis ,

Atreca (NASDAQ:BCEL) Stock Price Down 0.5%

Shares of Atreca, Inc. (NASDAQ:BCEL – Get Rating) were down 0.5% during trading on Tuesday . The company traded as low as $0.88 and last traded at $0.91. Approximately 58,366 shares changed hands during mid-day trading, a decline of 64% from the average daily volume of 162,452 shares. The stock had previously closed at $0.91. […] ....

Dimensional Fund Advisors , Atreca Inc , Ef Hutton Acquisition Co , Ensign Peak Advisors Inc , Millennium Management , Raymond James Associates , Virtu Financial , Get Rating , Capital Management , Peak Advisors Inc , Fund Advisors , Atreca Daily , Nasdaq Bcel ,

Atreca Announces Oral Presentation of ATRC-101 Phase 1b Study Data at ASCO 2023 Annual Meeting

SAN CARLOS, Calif., April 26, 2023 Atreca, Inc. , a clinical-stage biotechnology company focused on developing novel cancer therapeutics generated through a unique discovery platform based on. | April 26, 2023 ....

United States , Bartosz Chmielowski , Herb Cross , Alex Gray , Exchange Commission , American Society Of Clinical Oncology , Health Sciences Clinical Professor Of Medicine , Atreca Inc , University Of California Los Angeles , Division Of Hematology , American Society , Clinical Oncology , Developmental Therapeutics , Health Sciences Clinical Professor , California Los , Private Securities Litigation Reform Act , Annual Report , Quarterly Report , Nc Stock Exchange , Press Release , Ased Bcel Us04965g1094 ,